Work

Pharmacoeconomics of Oral Weight-lowering Drugs in Type 2 Diabetes: a Comparative Study of Sglt-2 Inhibitors and Glp-1 Analogues in India

Year: 2025
Type: article
Abstract: Objective:To assess the affordability and adherence implications of SGLT-2 inhibitors and GLP-1 analogues in the Indian context, with a focus on Pharmacoeconomics and cost variations Methods:Medication price data were collected from the Current Index of Medical Specialties (CIMS) and accredited online sources for SGLT-2 inhibitors and GLP-1 analogues from January 2024 to April 2024. Percentage cost variation was calculated to analyse price differences among brands. Results: SGLT-2 inhibitors, particularly dapagliflozin, exhibited significant price variations, with costs ranging from INR 5.9 to INR 30 per tablet. Combination therapies showed moderate variations, while GLP-1 analogues, including oral semaglutide, were substantially more expensive, ranging from INR 294.81 to INR 387 per tablet. Conclusion: The study underscores the need for cost-effective prescribing practices to improve affordability and adherence, particularly for resource-constrained settings in India. Integration of these drugs into essential medicine lists and price regulation could alleviate financial strain and enhance accessibility.
Institution: Saveetha University
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7216699340
FWCI: 0.432
Cites: 17
Cited by: 1
Related to: 10